. 2019 Dec 5;8(1):379–389. doi: 10.1002/fsn3.1318

Table 5.

Activities of SOD, GSH, GSH‐Px, CAT, and MDA in liver of mice (n = 10)

Group	SOD (U/mg prot)	GSH (mg/g prot)	GSH‐Px (U/mg prot)	CAT (U/mg prot)	MDA (nmol/mg prot)
Normal	245.42 ± 23.33^d	66.44 ± 11.07^e	1,129.11 ± 79.07^e	145.92 ± 12.22^b	77.13 ± 7.64^d
Control	169.45 ± 4.09^b	35.07 ± 4.01^ab	882.63 ± 80.02^a	102.50 ± 7.45^e	141.52 ± 16.88^a
LB	182.24 ± 15.75^b	33.12 ± 2.09^a	975.35 ± 94.35^bc	108.13 ± 17.74^a	60.40 ± 10.46^ab
VitC	242.40 ± 12.81^cd	46.16 ± 2.78^cd	1,070.42 ± 66.58^d	125.73 ± 4.83^bc	85.78 ± 7.27^c
KSFY06‐H	227.68 ± 22.27^c	50.63 ± 7.23^d	1,010.95 ± 96.03^cd	124.66 ± 19.24^cd	97.52 ± 7.78^c
KSFY06‐L	144.69 ± 19.30^a	39.72 ± 5.64^bc	902.45 ± 53.63^ab	115.07 ± 12.86^d	96.06 ± 12.19^b

Data are means ± SD (n = 10/group). ^a–e In the same column, different letters indicated significant differences between the two groups (p < .05), and the same letters indicated no significant difference between the two groups (p > .05) according to Duncan's multirange test. Normal = normal mice; Control = mice treated with d‐galactose injection (120 mg/kg per day); VitC = mice treated with d‐galactose and vitamin C (100 mg/kg per day); KSFY06 = mice treated with d‐galactose and increasing doses (L, H) of Lactobacillus plantarum KSFY06 (2 × 10⁸, 2 × 10⁹ cfu/kg per day); and LB = mice treated with d‐galactose and Lactobacillus delbrueckii subsp. bulgaricus (2 × 10⁹ cfu/kg per day).